Corbion N.V.
CSNVF
Other OTC22.24
USD
+0.07
- -
ISIN
NL0010583399
Return %
Stock
S&P500
1Y
5.70
18.99
3Y
-3.85
64.75
5Y
-58.04
71.84
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Olivier Rigaud
- Full Time Employees
- 2,408
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- Piet Heinkade 127 Amsterdam NH Netherlands 1019 GM
- IPO Date
- Jan 7, 2014
- Website
- corbion.com
- Similar Companies
- Business
- Corbion N.V. (CSNVF) manufactures and markets sustainable biobased ingredients, primarily lactic acid and derivatives, food preservation solutions, functional blends, and algae ingredients; it operates through Food and Biochemicals segments serving food production, health, animal nutrition, home and personal care, pharmaceuticals, electronics, medical devices, and bioplastics industries worldwide. Founded in 1919 and headquartered in Amsterdam, Netherlands, the company leverages fermentation technology with production sites across Europe, North America, Asia-Pacific, and Latin America, generating €1,332.0 million in annual sales in 2024 from 2,399 employees. Core offerings include fermentation-derived lactic acid for preservation in meat, dairy, bakery, and plant-based foods; omega-3 algae ingredients like AlgaPrime DHA for aquaculture and pet nutrition; biochemicals such as lactates and vinegars; bread improvers; and natural mold inhibitors like Verdad Essence WH100 and egg replacers for clean-label baking. Recent strategic developments feature the divestiture of its low-growth emulsifier business to Kingswood Capital Management for $362 million in cash, yielding net proceeds of about $275 million, to sharpen focus on high-growth specialty food ingredients; completion of the Advance 2025 plan with margin expansion to 16%, 9% revenue CAGR, and positive free cash flow for ten quarters; and launch of the Bright 2030 initiative emphasizing specialty innovations. Corbion expanded capacities with a new lactic acid plant in Rayong, Thailand; acquired Novotech's bread improver business to strengthen India presence; acquired a vinegar facility in North America; and upgraded facilities in Mexico while introducing products like Verdad Essence WH100 and AI-enhanced Listeria Control Model. Ongoing efforts include share buybacks totaling €30 million in 2024-2025, a USD 100 million US Private Placement debt issuance, partnerships with BRAIN Biotech, Kuehnle AgroSystems, and IMCD for distribution, and sustainability accolades like EcoVadis Platinum and CDP A- scores.
Corbion N.V. (CSNVY) Q1 2026 Earnings Call Transcript
Corbion N.V. (CSNVY) Q4 2025 Earnings Call Transcript
Corbion N.V. (CSNVY) Analyst/Investor Day Transcript
Corbion reports the progress of its share buyback program 6 October – 10 October 2025
Corbion reports the progress of its share buyback program 29 September – 3 October 2025
Corbion joins the Ferment4Health Project to unlock the gut health potential of fermented foods
Corbion General Shareholders Meeting approves Board (re)appointments and dividend
Corbion N.V. (CSNVF) Q4 2024 Earnings Call Transcript